Losing Weight with PCOS: Why Standard Diets So Often Fail
For many women with PCOS, insulin resistance is at the center. In that case, weight is often more of a symptom than a cause. Here you will learn why calorie counting alone can be so frustrating for that reason, and why steady blood sugar could be the better compass.
PCOS usually ends up at the gynecologist's practice, and that is where it belongs. But for many women, a large part of the story plays out in the metabolism. In that case, your weight is often not the cause. It is a symptom.
You tried again. Skipped breakfast, a salad at lunch, almost nothing in the evening. After three weeks, the scale shows the same number as before.
And your hunger is louder than ever. Maybe you then heard that sentence again: just eat less and move more. As if that were not exactly what you had been doing all along.
If you have PCOS, you probably know this feeling well. Today I would like to offer you a different explanation. Not an excuse, but physiology.
For many women with PCOS, it is not the plate that is at the center, but the hormone insulin. And as long as insulin sets the pace, losing weight can feel like rowing against the current.
I know this pattern very well. Imagine a young woman who has known for years that she has PCOS. She has tried almost every diet, often with iron discipline.
Her words during the consultation: “I barely eat anything. Still, I am not losing weight, and two hours after eating I am hungry again.”
Her fasting blood sugar had been unremarkable at every checkup. Only a look at insulin and at the blood sugar curve after eating made the pattern visible. Her body needed a great deal of insulin to keep blood sugar within range.
The turning point was not a stricter plan, but a different focus. Away from calorie counting, toward meals that keep her full and keep blood sugar steady. Strength training and more attention to sleep were added.
After a few months, she reported that her cravings had become quieter and her cycle was coming more regularly. The scale moved more slowly than she would have liked, but it moved. I cannot derive causality from this, but I see this temporal connection again and again.
It was not her discipline that was weak. Her metabolism had been working against her.
What to expect in this article
- Why PCOS is also a metabolic diagnosis
- How insulin resistance develops in PCOS
- Why the ovary still listens to insulin
- Three reasons why diets so often frustrate
- What role inflammation and sleep play
- What diet, training and medication can do
- Three levers for your start
- Answers to common questions
PCOS is more than an ovary issue
Do you remember the moment of your diagnosis? For many women, it was about irregular periods, about skin and hair. Or about a wish for a child that would not come true.
Metabolism may have come up only briefly in that conversation. For your weight, though, it may be the most important part of the story.
PCOS stands for polycystic ovary syndrome. The name is a little misleading. The ultrasound does not show real cysts, but many small follicles, little egg sacs that have stopped on their way to ovulation. Lined up, they sometimes look like a string of pearls.
The diagnosis is usually based on the Rotterdam criteria. Two of three features must apply: infrequent or absent ovulation, signs of too many male hormones in the blood or on skin and hair, and the typical appearance of the ovaries. Other causes, such as thyroid or prolactin disorders, must be ruled out first. The 2023 international guideline also allows the hormone value AMH as an alternative to ultrasound in adults.
A Turkish research group pooled 24 studies on how common PCOS is. According to the Rotterdam criteria, around 10 percent of women had PCOS, and according to the narrower NIH criteria, around 6 percent. What this means for you: with this diagnosis, you are anything but alone.
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. Hum Reprod. 2016. DOI: 10.1093/humrep/dew218An international team led by Monash University in Melbourne updated the PCOS guideline in 2023, supported by 39 organizations from 71 countries. More than before, it emphasizes the risks for metabolism, heart and sleep apnea, starts with a healthy lifestyle and calls for weight stigma to be taken seriously. What this means for you: experts today also see PCOS as a diagnosis that affects the whole body.
Teede HJ, Tay CT, Laven J et al. Fertil Steril. 2023. DOI: 10.1016/j.fertnstert.2023.07.025Try reading the guideline through the lens of your weight. Then one thing stands out: metabolism, heart and sleep sit right next to cycle and fertility.
PCOS is not only a diagnosis for your ovaries. For many women, it is also a diagnosis for metabolism.
Gynecological testing is important and makes sense: it clarifies cycle, hormones and ultrasound findings. An integrative view can add a look at insulin, muscle, sleep and inflammation. That is often exactly where the levers for your weight lie.
And now you know why, with PCOS, it is worth looking not only at the ultrasound, but also at your metabolism.
Insulin resistance: when the key sticks
Maybe your fasting blood sugar was unremarkable at every checkup. Still, after lunch you feel as if someone switched you off. And an hour later, the hunger is already back.
That does not add up? Actually, it can add up very well.
Insulin is a key. After a meal, it unlocks your muscle and fat cells so that sugar from the blood can get in. Inside the cell, small sugar gates then move to the surface. They are called GLUT4.
With insulin resistance, this lock sticks. Your pancreas reacts the way you would react to a sticking door: it pushes harder and releases more insulin.
This can go well for years. Blood sugar stays within range because insulin is working overtime. That is why your fasting blood sugar can look normal while your insulin level has long been elevated.
A team from Melbourne measured insulin sensitivity in 73 women using the clamp method, the gold standard, in which insulin and sugar are infused into a vein in a controlled way. Insulin resistance was found in 75 percent of lean women with PCOS, 62 percent of overweight women without PCOS and 95 percent of overweight women with PCOS. What this means for you: with PCOS, insulin resistance is not purely a question of body shape. Lean women can be affected too.
Stepto NK, Cassar S, Joham AE et al. Hum Reprod. 2013. DOI: 10.1093/humrep/des463The same research group later analyzed 28 clamp studies together. On average, women with PCOS had 27 percent lower insulin sensitivity than women without PCOS, independent of BMI, and a low SHBG went along with worse values. What this means for you: for many women, insulin resistance is part of the core of PCOS and not merely a consequence of weight.
Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Hum Reprod. 2016. DOI: 10.1093/humrep/dew243Where exactly does it stick? In PCOS, the disruption often sits behind the lock. A signaling protein called IRS-1 receives chemical tags in the wrong place inside the cell. Imagine a stone in a gear: the key turns, but inside, the signal arrives only muffled.
Why the ovary still listens
Now it gets interesting. Insulin resistance in PCOS is often selective. Imagine a house with two doors. The door for sugar uptake sticks. The door through which insulin passes on other commands stays open.
One of these open doors leads into the ovary. There, insulin amplifies the signal of the hormone LH. The theca cells, small hormone factories around the follicles, then produce more male hormones, the androgens.
At the same time, a lot of insulin can cause the liver to produce less SHBG. SHBG is like a taxi that holds on to testosterone in the blood. Fewer taxis mean more free testosterone. This can show up in your skin, hair and cycle.
And the androgens keep the wheel turning, because they in turn can intensify insulin resistance. This creates a loop that keeps driving itself. On top of that comes a predisposition: researchers have found several gene loci linked to PCOS.
Two researchers summarized the state of knowledge on insulin and PCOS in the journal Endocrine Reviews. They describe a pronounced insulin resistance that can occur independently of excess weight, and an insulin signal that is muffled in metabolism but remains active in the ovary. What this means for you: from this perspective, PCOS is also a metabolic disorder and not only a reproductive disorder.
Diamanti-Kandarakis E, Dunaif A. Endocr Rev. 2012. DOI: 10.1210/er.2011-1034The loop in four steps
Cells listen poorly
Muscle and fat cells respond sluggishly to insulin. Sugar stays in the blood longer.
More insulin
The pancreas compensates and releases more insulin. The body switches to storage.
Hormonal consequences
The ovary produces more androgens, the liver less SHBG. Free testosterone rises.
Noticeable consequences
Hunger, belly fat, an irregular cycle. And the androgens can further intensify insulin resistance.
For many women with PCOS, the problem is not a lack of insulin. Rather, too much of it is circulating, because the cells are not listening well.
That changes the question. Not: how can I get even fewer calories into me? But: how can my body manage with less insulin? Insulin is then often what sets the pace, and your weight is more of a symptom.
And now you know why your blood sugar can be unremarkable while your insulin has long been working overtime.
Why standard diets so often fail when losing weight with PCOS
You count. You go without. You hold on, often longer than others. And still, your body does not seem to play along.
At some point, a quiet thought creeps in: maybe it is me after all. Let us look at this thought together.
Reason 1: Insulin switches to storage
Insulin is not just a key for sugar. It is also your body's most important storage hormone. As long as it is high, your fat cells carry a sign: deliveries only, no pickups.
In the fat cell, insulin slows down the enzymes that release fat from storage. If your insulin level is permanently elevated because of the resistance, fat breakdown can become sluggish. Even when you eat little.
Reason 2: Your hunger speaks a different language
Ghrelin is your stomach's hunger bell. Normally, it gets quieter after a meal. In PCOS, this does not always seem to work so well.
An Australian research group had overweight women with and without PCOS lose weight for twelve weeks on either a high-protein or a standard diet and then maintain their weight for four weeks, measuring their hunger along the way. After a test meal, the women with PCOS felt less full and hungrier, and after weight loss, their ghrelin fell after eating by only 28.9 pg/ml, compared with 144.1 pg/ml in the women without PCOS. What this means for you: your constant hunger does not have to be a lack of willpower. It can be a measurable signal from your body.
Moran LJ, Noakes M, Clifton PM et al. J Clin Endocrinol Metab. 2004. DOI: 10.1210/jc.2003-031583Remarkably, whether the diet was high in protein or not made no difference to these hunger signals in the study. This suggests that it had less to do with the recipe than with metabolism.
This is where your nervous system comes into play. Your hunger control center sits in the hypothalamus, a small area deep in the brain. Its nerve cells carry insulin receptors themselves and use them to read how well supplied you are. The review in Endocrine Reviews describes this insulin signal in the brain as important for body weight and ovulation. If it arrives muffled, the feeling of fullness might become quieter. This is mechanistically plausible, but it has been studied very little in women with PCOS so far.
Reason 3: Your engine may run more economically
A Greek research group measured the basal metabolic rate in 91 women with PCOS and 48 women without PCOS, meaning the energy your body uses at complete rest. After matching for age and BMI, it averaged 1,116 kilocalories per day in women with PCOS and insulin resistance, and 1,868 in women without PCOS. What this means for you: if these figures are confirmed, the same diet may achieve less for you than for your friend, but this is a single, small study.
Georgopoulos NA, Saltamavros AD, Vervita V et al. Fertil Steril. 2009. DOI: 10.1016/j.fertnstert.2008.04.067What lifestyle studies show on average
A Cochrane team analyzed 15 randomized trials with 498 women on lifestyle programs for PCOS. Compared with minimal or no support, the women lost 1.68 kilograms more on average, and the free androgen index, a measure of active male hormones, fell. What this means for you: the scale often responds slowly, while something may already be shifting in the hormonal system, although the authors rate the quality of the studies as low.
Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Cochrane Database Syst Rev. 2019. DOI: 10.1002/14651858.CD007506.pub4That sounds sobering. But look more closely: averages hide large differences. And they say little about how well a program fit your metabolism.
If a diet has failed for you, that does not prove that you failed. Perhaps it only shows that the approach did not fit your metabolism.
With PCOS, a strict calorie deficit fights three opponents at once: a lot of insulin, loud hunger signals and possibly a more economical engine. That is not a fair contest. And no reason to feel ashamed.
I describe in more detail why a calorie is not just a calorie in the article on the calorie myth. And you can read about which other feedback loops can slow you down in the article Why am I not losing weight when I eat so little?
And now you know why discipline alone so rarely wins against a metabolism that is set to storage.
Inflammation and sleep: the quiet amplifiers
You sleep eight hours and wake up as if you had barely slept? You feel exhausted during the day without knowing why?
Many women with PCOS know this. You often blame it on stress or a lack of willpower. Yet it can be closely linked to your metabolism.
A fire you cannot feel
An international research team pooled 31 studies on inflammation markers in PCOS. CRP, an inflammation marker made by the liver, was 96 percent higher on average in women with PCOS, even independently of excess weight, while the messenger substances IL-6 and TNF-α did not differ clearly. What this means for you: with PCOS, a quiet, chronic inflammation may be running in the background that you cannot feel, but that can be measured.
Escobar-Morreale HF, Luque-Ramírez M, González F. Fertil Steril. 2011. DOI: 10.1016/j.fertnstert.2010.11.036How is this connected to insulin? Imagine inflammatory messengers as jamming transmitters. Some of them can come from immune cells in belly fat that act there like a fire brigade on permanent duty. In muscle and fat cells, these messengers can activate enzymes that tag that very signaling protein, IRS-1, in the wrong place. The insulin signal then becomes even quieter. This is well described in cell and animal studies. How large its share is in women with PCOS remains open.
When the night is no break
A British team analyzed 17 studies with 648 women with PCOS on sleep apnea, meaning pauses in breathing at night. Thirty-five percent of the women were affected, the odds of it were around 3.8 times higher than in women without PCOS, and sleep apnea was clearly more common in women with obesity than in lean women. What this means for you: snoring, unrefreshing sleep and daytime tiredness are a good reason for a medical evaluation, even though many of the studies have methodological weaknesses.
Kahal H, Kyrou I, Uthman OA et al. Sleep Breath. 2020. DOI: 10.1007/s11325-019-01835-1What happens in your body? With every pause in breathing, oxygen drops briefly. Your nervous system sounds the alarm, like a smoke detector that keeps going off. Stress hormones rise, the liver releases sugar, and the cells can respond even more sluggishly to insulin. Poor sleep can also make you hungrier the next day.
It is no coincidence that the international guideline explicitly names sleep apnea as a topic in PCOS. You can find out how night and weight are connected in the article on sleep and weight loss.
From the perspective of functional medicine, I therefore ask not only: what do you eat? But also: how do you sleep? How much muscle do you carry? And is there a silent inflammation running somewhere in the background?
When it comes to losing weight, your sleep is not a side issue. It is metabolic work.
The night can help decide how hungry you are the next day and how well your cells listen to insulin. A weight loss plan that ignores sleep is driving with the handbrake on.
And now you know why a good plan for PCOS does not stop at the plate.
What can support steady blood sugar
Maybe you are now asking yourself: so what should I do? Eat even less? No. Rather eat differently, train differently, sleep differently.
Here I am giving you directions, not a rigid recipe. What exactly suits you depends on your lab values, your daily life and your goals.
Eating for steady blood sugar
Imagine your blood sugar as a fire in a fireplace. Newspaper flares up brightly and burns out right away. A log burns calmly and for a long time. Foods with a low glycemic index are the logs.
A research group from Sydney had 96 women with PCOS and excess weight eat either a low glycemic index diet or a conventional healthy diet. Among the women who stayed until the end, insulin sensitivity in the oral glucose tolerance test improved more on the low-GI diet, and the cycle became more regular in 95 instead of 63 percent of the women. What this means for you: with PCOS, not only how much but also which carbohydrates you eat can matter, even though almost half of the participants did not complete the study.
Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC. Am J Clin Nutr. 2010. DOI: 10.3945/ajcn.2010.29261In everyday life, this means: protein and vegetables form the basis of your meals. Carbohydrates can stay, ideally in high-fiber form, such as legumes, whole grains or oats instead of white bread and juice. And starving yourself is rarely a good idea with PCOS, because it can make the already loud hunger signals even louder. You can find more on this in the article on blood sugar spikes and nutrition.
Muscles as a sugar sponge
Your biggest sugar consumer is your muscle. A working muscle fiber takes sugar from the blood, including through a second pathway that does not need insulin. With insulin resistance, this is a valuable detour.
A team from Australia and Norway summarized 19 exercise studies with 777 women with PCOS. Intensity mattered most: vigorous training increased cardiorespiratory fitness by around 24 percent, lowered the insulin resistance index HOMA-IR by around 36 percent and reduced waist circumference. What this means for you: it can be worth really challenging yourself now and then. The authors suggest at least 120 minutes of vigorous training per week.
Patten RK, Boyle RA, Moholdt T et al. Front Physiol. 2020. DOI: 10.3389/fphys.2020.00606A Brazilian research group had women with and without PCOS do progressive strength training three times a week for four months. In the women with PCOS, testosterone and waist circumference decreased and muscle mass increased, while overall metabolism barely changed. What this means for you: with PCOS, strength training can act on the hormone profile and body composition, even if not every metabolic value follows right away.
Kogure GS, Miranda-Furtado CL, Silva RC et al. Med Sci Sports Exerc. 2016. DOI: 10.1249/MSS.0000000000000822I explain in detail how muscles work as a blood sugar buffer in the article on strength training for insulin resistance.
Medication and supplements, viewed objectively
Conventional medicine uses medications for PCOS depending on the goal, and that makes sense. The pill can bring about regular bleeding and ease signs of androgens on skin and hair. Metformin can target insulin resistance. An integrative approach can add nutrition, exercise, sleep and a look at inflammation. One does not exclude the other.
A team from Melbourne analyzed 12 randomized trials with 608 women on metformin and lifestyle in PCOS. Metformin in addition to lifestyle changes lowered BMI by a further 0.73 points and improved the cycle, while metformin alone performed similarly to lifestyle changes alone for BMI. What this means for you: metformin can be one building block, but it does not replace lifestyle, and in Germany it is not approved for PCOS and can only be used off-label for it.
Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Hum Reprod Update. 2015. DOI: 10.1093/humupd/dmv025For the 2023 guideline, an international team analyzed 30 studies with 2,230 women on inositol, a sugar-like substance involved in insulin signaling. Inositol showed possible benefits for some metabolic values, D-chiro-inositol perhaps for ovulation, and myo-inositol probably caused fewer gastrointestinal complaints than metformin, but the data remained limited and inconclusive. What this means for you: inositol is an option you can discuss with a doctor, but not a proven substitute for other approaches.
Fitz V, Graca S, Mahalingaiah S et al. J Clin Endocrinol Metab. 2024. DOI: 10.1210/clinem/dgad762GLP-1 receptor agonists, often called the weight loss injection, mimic a satiety hormone from the gut. They can markedly dampen appetite and slow down stomach emptying. They are not approved for PCOS itself. Depending on the product, they are approved for type 2 diabetes or, under certain conditions, for weight management in obesity and in overweight with related conditions. They are not intended for use during pregnancy, so if you want to have a child, stopping them requires careful medical planning.
A 2026 network meta-analysis compared 16 randomized trials on GLP-1 receptor agonists, metformin and inositol in women with PCOS. Compared with the control groups, GLP-1 receptor agonists alone lowered weight by around 5.2 kilograms on average and waist circumference by 4.7 centimeters, and by around 5.6 kilograms when combined with metformin, but there was no significant effect on the insulin resistance index HOMA-IR. What this means for you: these medications can have a marked effect on weight, but the studies varied widely, fertility was not examined, and according to the authors, lifestyle remains the first step.
Omarion A, Ayasa Y, Omarion Z, Jayouse B, Ayesh H. Front Endocrinol (Lausanne). 2026. DOI: 10.3389/fendo.2026.1833904A team from Leicester analyzed 36 randomized trials on GLP-1 receptor agonists and on SGLT2 inhibitors, another group of diabetes medications, three of them in women with PCOS. On GLP-1 receptor agonists, participants lost 1.51 kilograms more fat-free mass on average than in the control groups, and across both medication groups, around 28 percent of the weight loss was fat-free mass. What this means for you: if you use such a medication, it is especially worthwhile to protect your muscles with protein and strength training and to have your body composition measured.
Jobanputra R, Sargeant JA, Plekhanova T et al. Diabetes Metab Res Rev. 2026. DOI: 10.1002/dmrr.70194Supported by large RCTs / meta-analyses: Insulin resistance is common in PCOS and partly independent of BMI. In studies, lifestyle programs lowered weight and the free androgen index slightly on average, with low quality of evidence. Vigorous training can lower HOMA-IR. Metformin and GLP-1 receptor agonists can additionally have an effect on weight.
Mechanistically plausible, human studies still thin: A muffled insulin signal in the brain might weaken the feeling of fullness. Silent inflammation might further disrupt the insulin signal in the cell. Whether basal metabolic rate is markedly lower in PCOS with insulin resistance is something larger studies still need to show.
Clinically, I observe that many women with PCOS describe early, strong hunger after carbohydrate-rich meals. Meals with plenty of protein and fiber, strength training and protected sleep can often be sustained longer than any strict diet. This is experience, not proof.
The goal is not the smallest number on the scale. The goal is a metabolism that works with you again instead of against you.
When insulin falls, hunger gets quieter and muscles grow, weight can follow. Sometimes more slowly than you would like. But on a path that does not wear you down.
And now you know why, with PCOS, steady blood sugar can be a better compass than the calorie count.
Three levers for your start
You do not have to change everything at once. Three levers are enough to begin with.
Have your glucose metabolism checked more closely
Fasting blood sugar alone often shows too little. The international guideline recommends checking glucose metabolism in all women with PCOS, including lean women. Ask about an oral glucose tolerance test. If you snore or feel leaden with tiredness during the day, your sleep belongs on the list too.
Eat for steady blood sugar, not for a deficit
Build your meals around protein and vegetables. Choose carbohydrates that burn slowly, like a log. And let go of starving yourself: with PCOS, regular, filling meals are often the more stable path than a harsh calorie deficit.
Make your muscles your allies
Strength training two or three times a week can expand your sugar storage. Now and then, add vigorous sessions that leave you out of breath. Start slowly and build up step by step.
With PCOS, it is not only about the kilos. It is about a body that can carry you through the day again: without afternoon cravings, without leaden tiredness, without the feeling of constantly fighting against yourself. Energy is not a luxury. Energy is freedom.
If you want to do more than read and get started right away: below this article, you will find the option to book an appointment.
Frequently asked questions
Can I lose weight with PCOS at all?
Why am I not losing weight with PCOS despite dieting?
Do all women with PCOS have insulin resistance?
Which diet makes sense with PCOS?
Which type of exercise suits PCOS?
Is metformin approved for PCOS?
What can inositol do for PCOS?
Is the weight loss injection an option with PCOS?
Which blood tests make sense for PCOS and weight?
Can PCOS affect sleep?
Where this topic connects
Insulin, hunger, muscles and hormones are closely connected. These articles explore the neighboring levels in more depth.
Why am I not losing weight when I eat so little?
Which feedback loops may be behind the plateau.
Weight lossRecognizing insulin resistance
How you notice it and what can change.
MetabolismInsulin resistance and weight loss
Why metabolism has a say in weight loss.
Weight lossThe calorie myth
Why calorie counting does not add up for many people.
Weight lossCravings for sweets
Causes beyond a lack of discipline.
Weight lossAvoiding blood sugar spikes
How your plate can shape the glucose curve.
NutritionPreserving muscle while losing weight
Why muscles are your most important metabolic partner.
Weight lossStrength training for insulin resistance
Muscles as a blood sugar buffer.
ExerciseSleep and weight loss
What the night has to do with your hunger.
SleepSilent inflammation and weight
How quiet inflammation can slow down metabolism.
Immune systemThe weight loss injection
What GLP-1 medications can do and where their limits are.
MedicationHormonal imbalance in women
An overview of your hormonal system.
HormonesSources
All studies were checked via PubMed against title, authors, year, journal and DOI. Figures on study results come from the respective abstracts. The study type is shown in square brackets. For context: the statements on insulin resistance are based on clamp measurements and meta-analyses, and the data on hunger and basal metabolic rate on smaller single studies. The lifestyle and training studies are mostly small and differ in design, and the medication studies mainly measure weight and metabolic values.
- Teede HJ, Tay CT, Laven J et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril. 2023;120(4):767-793. DOI: 10.1016/j.fertnstert.2023.07.025 [Systematic review: international guideline based on 52 systematic reviews]
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-2855. DOI: 10.1093/humrep/dew218 [Meta-analysis, 24 studies]
- Stepto NK, Cassar S, Joham AE et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777-784. DOI: 10.1093/humrep/des463 [Pathophysiology: clamp cross-sectional study, n=73]
- Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619-2631. DOI: 10.1093/humrep/dew243 [Meta-analysis, 28 clamp studies]
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030. DOI: 10.1210/er.2011-1034 [Mechanism review]
- Georgopoulos NA, Saltamavros AD, Vervita V et al. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril. 2009;92(1):250-255. DOI: 10.1016/j.fertnstert.2008.04.067 [Pathophysiology: prospective measurement, n=139]
- Moran LJ, Noakes M, Clifton PM et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab. 2004;89(7):3337-3344. DOI: 10.1210/jc.2003-031583 [RCT, n=32]
- Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-1058. DOI: 10.1016/j.fertnstert.2010.11.036 [Meta-analysis, 31 studies]
- Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3(3):CD007506. DOI: 10.1002/14651858.CD007506.pub4 [Meta-analysis, Cochrane, 15 RCTs, n=498]
- Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr. 2010;92(1):83-92. DOI: 10.3945/ajcn.2010.29261 [RCT, n=96]
- Patten RK, Boyle RA, Moholdt T, Kiel I, Hopkins WG, Harrison CL, Stepto NK. Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Physiol. 2020;11:606. DOI: 10.3389/fphys.2020.00606 [Meta-analysis, 19 studies, n=777]
- Kogure GS, Miranda-Furtado CL, Silva RC, Melo AS, Ferriani RA, De Sá MF, Dos Reis RM. Resistance Exercise Impacts Lean Muscle Mass in Women with Polycystic Ovary Syndrome. Med Sci Sports Exerc. 2016;48(4):589-598. DOI: 10.1249/MSS.0000000000000822 [Case-control intervention study, non-randomized, n=97]
- Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560-574. DOI: 10.1093/humupd/dmv025 [Meta-analysis, 12 RCTs, n=608]
- Fitz V, Graca S, Mahalingaiah S et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630-1655. DOI: 10.1210/clinem/dgad762 [Meta-analysis, 30 studies, n=2,230]
- Kahal H, Kyrou I, Uthman OA et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24(1):339-350. DOI: 10.1007/s11325-019-01835-1 [Meta-analysis, 17 studies, n=648]
- Omarion A, Ayasa Y, Omarion Z, Jayouse B, Ayesh H. Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis. Front Endocrinol (Lausanne). 2026;17:1833904. DOI: 10.3389/fendo.2026.1833904 [Meta-analysis: network meta-analysis, 16 RCTs]
- Jobanputra R, Sargeant JA, Plekhanova T, James E, Almaqhawi A, Webb DR, Davies MJ, Yates T. The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Diabetes Metab Res Rev. 2026;42(5):e70194. DOI: 10.1002/dmrr.70194 [Meta-analysis, 36 RCTs on GLP-1 receptor agonists and SGLT2 inhibitors]
This article is for information purposes and does not replace medical advice. It describes connections from research and clinical experience, not individual treatment instructions. If you are pregnant, want to become pregnant or use medications such as metformin or GLP-1 receptor agonists, please discuss any changes with a doctor in person.